Trial Summary
What is the purpose of this trial?This trial is testing a new treatment called NCS-01 to see if it is safe for patients who have recently had a stroke. The study will check how well patients tolerate the treatment.
Eligibility Criteria
This trial is for men and women aged 18-85 who've had a recent stroke with certain levels of neurological deficits. They must be able to undergo an MRI, not have cancer in the last 5 years, no organ transplants, not in another drug study recently, and women must use birth control.Inclusion Criteria
Women of child bearing potential who agrees to take acceptable birth control as described in the ICF
Provide written informed consent before participation, either by patient or a legal representative
I am between 18 and 85 years old.
+2 more
Exclusion Criteria
You cannot have an MRI scan.
I have not had any other cancers in the last 5 years.
You have had a bad reaction to similar treatments before.
+6 more
Participant Groups
The trial is testing NCS-01's safety and how well it's tolerated in those with acute ischemic stroke. Patients are randomly chosen to receive this treatment within 48 hours after their stroke starts. The study has two stages and includes multiple centers.
2Treatment groups
Experimental Treatment
Placebo Group
Group I: NCS-01Experimental Treatment1 Intervention
human bone marrow derived cells
Group II: shamPlacebo Group1 Intervention
sham procedure
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of MiamiMiami, FL
The University of TexasHouston, TX
Loading ...
Who Is Running the Clinical Trial?
NC Medial Research IncLead Sponsor